INCONTINENTIA PIGMENTI

  •  

    INCONTINENTIA PIGMENTI

     

    DEFINITION:

    A neurocutaneous syndrome characterized by cutaneous, neurologic (neonatal seizures), and ocular manifestations.

    EPIDEMIOLOGY:

    • incidence: over 700 cases reported
    • age of onset:
      • first few weeks of life
    • risk factors:
      • familial - x-linked dominant
        • chrom.#: Xq28 (familial type); Xp11.21-cen. (IP1)
        • gene: ?
      • F > M (20:1)
      • lethal in males

    PATHOGENESIS:

    1. Background

    • first described by M. Bardach in 1925
    • also called Bloch-Sulzberger Syndrome or Disease
    • is considered a disorder of the ectoderm involving multiple systems (i.e., skin, eyes, teeth, hair, bone, nervous system)

    CLINICAL FEATURES:

    1. Cutaneous Manifestations - 4 phases

    1. Vesicular Phase

    • begins at birth or within the first few weeks of life
    • linear, erythematous (red) streaks with plaques of vesicles which are replaced by bullae (blisters)
    • lesions appear on the limbs and around the trunk
    • this phase usually resolves by 4 months of age but blisters may develop during fevers throughout childhood

    2. Verrucous Phase

    • replaces the vesicular phase at about 4 months of age
    • the blisters of the vesicular phase dry and become hyperkeratotic resulting in the formation of warty (verrucous) plaques
    • the plaques usually appear on the distal limbs, dorsum of hands and feet, and the scalp with the face and trunk usually spared
    • usually resolves by 10-12 months of age but may persist for years

    3. Pigmentary Phase

    • the hallmark of IP
    • usually develops after the verrucous phase but may be present at birth or begin to appear within the first few months of life
    • hyperpigmented lesions appear as macular whorls, flecks, reticulated patches, splashes, and linear streaks
    • hyperpigmentation appears on the trunk, axillae, and groin and may involve areas not affected in the first two phases
    • this phase usually persists throughout childhood, with the lesions beginning to fade in adolescence and often disappearing by age 16
    • some lesions may persist (especially those in the groin)

    4. Hypopigmentary Phase

    • usually develops after the pigmentary phase but may also occur during the 3rd phase
    • pale, hairless, and anhidrotic streaks or patches
    • these hypopigmented lesions usually appear on the flexor surface of the lower limbs but may also occur on the trunk and arms

    2. Neurologic Manifestations (33%)

    • neonatal seizures
    • developmental delay (motor and cognitive)
    • hemiparesis, spasticity, and/or paralysis
    • microcephaly
    • mental retardation (in about 10% of patients)

    3. Ocular Manifestations (>30%)

    • microphthalmus, strabismus, cataracts
    • vascular abnormalities of the retina
      • neovascularization, retinal ischemia, bleeding, retrolental fibroplasia, retinal detachment
    • retrolenticular masses, exudative chorioretinitis, optic nerve atrophy, ureitis, keratitis (inflammation of the cornea)
    • refractive errors, visual impairment, blindness (although about 90% of patients have normal vision)

    4. Dental (50-80%)

    • delayed eruption
    • late dentition, hypodontia, partial anodontia
    • conical teeth
    • impaction

    5. Others

    1. Alopecia (40-50%)

    • patchy or diffuse
    • hair may be thin and sparse and/or lusterless, wiry, and coarse

    2. Nail Dystrophy (40%)

    • ridging, pitting

    3. Musculoskeletal

    • short stature, shortened arms and legs, hemiatrophy, syndactyly, kyphoscoliosis

    INVESTIGATIONS:

    1. Serum

    • elevated IgE, eosinophilia
    • defective neutrophil chemotaxis

    2. Histopathology

    1. Vesicular Lesions

    • epidermal edema, intraepidermal vesicles filled with eosinophils

    2. Verrucous Lesions

    • epidermal hyperplasia, hyperkeratosis, papillomatosis

    3. Pigmentary Lesions

    • degeneration and loss of epidermal basal cells and melanin in the melanophages of the upper dermis

    MANAGEMENT:

    1. Supportive

    • no treatment for underlying disorder
    • multidisciplinary approach
      • Paediatrics, Neurology, OT, PT, Dentistry, Dermatology
      • Ophthalmologic evaluation within the first few months of life

    2. Prognosis

    • normal life span

    ADDITIONAL REFERENCES:

    1. Jones, K.L., Smith's Recognizable Patterns of Human Malformation (5th Edition), p. 502-503. (1997).
    2. Baraitser, M. and R.M. Winter, Color Atlas of Congenital Malformation Syndromes. p. 196-197. (1996).

    INTERNET LINKS:

    National Incontinentia Pigmenti Foundation

     

     

    Pediatric Database - INCONTINENTIA PIGMENTI

    Pediatric Organization - Pedbase [at] Gmail.com